Pall ForteBio Launches the Octet K2 System, Increasing Access to Sensitive Binding Interactions Analysis

Aug 04, 2015

PORT WASHINGTON, N.Y., August 4, 2015 — Pall ForteBio LLC, a leading supplier of instrumentation for accelerated drug discovery and development, today announced the launch of the Octet K2 system, a new entry point into the Octet line of label-free interaction analysis systems. Now available globally, the Octet K2 system offers high-performance, budget-friendly kinetic characterization of antibody, protein and small-molecule binding interactions.

Using Pall ForteBio’s Bio-Layer Interferometry (BLI) technology, all Octet systems offer a fluidics-free alternative to surface plasmon resonance with a variety of off-the-shelf Dip and Read™ biosensors for more rapid assay development and optimization. The Octet K2 system increases accessibility to BLI as a two-channel instrument that provides exquisite binding affinity data, for molecules down to 150 daltons in size.

"Label-free users in academia and at startup biotech companies have historically been stuck between choosing to pay a premium for capacity they will never use or to settle for a lower-performance ‘starter’ system,” commented Robert Wicke, General Manager at Pall ForteBio. “The Octet K2 system offers scientists throughput to meet their budget without compromising assay sensitivity."

About Pall ForteBio

Pall ForteBio LLC is a division of Pall Life Sciences that provides analytical systems to accelerate biotherapeutic drug discovery and development. These systems facilitate real-time, label-free analysis of biomolecular interactions, providing information on affinity, kinetics and concentration. Pall ForteBio's analytical solutions enable more efficient and accurate characterization of drug candidates, delivering greater value to the drug discovery and development markets.For more information, visit

About Pall Corporation

Pall Corporation (NYSE:PLL) is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company’s engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation is an S&P 500 company serving customers worldwide. Follow us on Twitter @PallCorporation or visit

Contact Information :
Gemma Milan
Pall ForteBio